The big people with lots of money are interested in buying Pfizer, a company that makes medicine. They are using something called options to try and make more money from the price of the medicine going up or down. Most of them think the price will go up, but some think it will go down. The important thing is they all see Pfizer's price staying between $20 and $30 in the near future. Read from source...

1. The title is misleading and sensationalized. It implies that there are some secret or exclusive actions of wealthy investors (whales) related to Pfizer (PFE), but the article does not deliver any evidence or analysis of their specific strategies or motives.
2. The article is poorly written, with many grammatical and syntactical errors, lack of clarity, coherence, and logical flow. It jumps from one topic to another without explaining the connection or relevance, and it uses vague terms like "bullish" and "bearish" without defining them or providing any context or examples.
3. The article is based on a very limited and outdated data set (options history for Pfizer) that may not reflect the current market situation or the actual intentions of the whales. It also does not mention how reliable or credible the source of this data is, or how it was obtained or verified.
4. The article uses vague and subjective terms like "price window" and "price target" without explaining how they are calculated or justified, or what criteria or methodology are used to determine them. It also does not provide any historical or comparative analysis of the performance or volatility of Pfizer's stock or options, or any external factors that may influence its value or demand.
5. The article tries to create a sense of urgency and excitement by using phrases like "whales with a lot of money", "noticeably bullish stance", "big players have been eyeing" without providing any actual evidence or support for these claims, or explaining why they are important or relevant for the readers. It also attempts to manipulate the emotions and expectations of the readers by using words like "what's the price target?", implying that there is some hidden or significant information that will be revealed later in the article, but it never does.

1. Pfizer has been performing well recently, with strong earnings reports and positive news about its COVID-19 vaccine. This indicates that the company is likely to continue growing in the short term, making it a good long position candidate for investors who are looking for stability and growth potential. However, there may be some risks associated with Pfizer's stock, such as regulatory changes, litigation, or adverse events related to its COVID-19 vaccine. These risks could negatively impact the company's financial performance and stock price in the future. Therefore, investors should carefully consider these factors before making any decisions regarding Pfizer's stock.